openPR Logo
Press release

Implantable Drug Delivery Devices Market Key Players : Bayer Healthcare, Boston Scientific Corporation, Allergan Inc., Medtronic Inc., Merck, Bausch and Lomb, Inc.

11-19-2018 10:14 AM CET | Health & Medicine

Press release from: Allied Market Research

Implantable Drug Delivery Devices Market

Implantable Drug Delivery Devices Market

Implantable drug delivery devices are the medical devices, which enable site specific drug administration. It also helps in minimizing the doses of drug in order to reduce potential side effects. These devices facilitate sustained release of a therapeutic agent. These implantable devices are gaining edge over conventional oral or parenteral dosage forms due to site specific and sustained release therapeutic action of implantable devices, which further minimize the side-effects associated with the drug.

Competitive Analysis

Bayer Healthcare, Boston Scientific Corporation, Allergan Inc., Medtronic Inc., Merck, Bausch and Lomb, Inc. and Abbott laboratories are some of the major players in this market. Product launch, merger & acquisition and research & development are the competitive strategies adopted by these key players. In 2013, Bayer Healthcare launched a noval hormonal intrauterine device (IUD) Skyla. The same product is launched in Europe with the brand name Jaydess, which is used for the prevention of pregnancy for up to three years.

Get Sample PDF Brochure : https://www.alliedmarketresearch.com/request-toc-and-sample/449

The major factors driving the growth of this market are growing incidences of target disease such as diabetic retinopathy, prostate cancer, cardiovascular diseases and chroni diseases. Rising cases of unwanted pregnancies and growing aging population also supplement the growth of this market. However, cost associated with the use of these devices has restricted the market growth.

Global Implantable Drug Delivery Devices Market by Product Types

Global implantable drug delivery devices market is segmented into Implantable coronary drug eluting stents, implantable bio-absorbable stents, implantable contraceptive drug delivery devices, implantable intraocular drug delivery devices, implantable brachytherapy seeds and implantable drug infusion pumps. Implantable drug infusion pumps and contraceptive drug delivery devices are most widely used devices.

Global Implantable Drug Delivery Devices Market by Technology

Global implantable drug delivery devices market by technology is segmented into Biodegradable implantable drug delivery device technology and Non-biodegradable implantable drug delivery device technology. Biodegradable technology is expected to grow faster as compared to Non-biodegradable, as biodegradable technology reduces side effects associated with the presence of device in the body and does not follow the process of surgery in removing a device from the body.

Global Implantable Drug Delivery Devices Market by Application

Global implantable drug delivery device market by application is segmented into Ophthalmology, cardiovascular, Birth control/contraception, Oncology and others. The market of implantable drug delivery devices is largest in cardiovascular application due to the introduction of absorbable stents devices.

Global Implantable Drug Delivery Devices Market by Geography

Geographically, the market is segmented into North America, Europe, Asia-Pacific and LAMEA. North America is the largest market due to growing aging population and prevalence of target disease such as diabetic retinopathy and chronic diseases. Asia-pacific is considered to be the fastest growing market due to high disposable income in emerging nations.

KEY BENEFITS

• The report throws light on the dominant current trends. Based on the understanding of trends, revenues are forecast from 2013-2020
• Market intelligence for key developmental strategies adopted by top companies is explained with impact analysis
• Analysis of trends in various regions would help the companies to plan their strategies depending on the region
• Emphasis is laid on key factors affecting the growth of global implantable drug delivery device market. These factors are critically analyzed to reveal the most impacting factors in the market
• Porter’s Five Forces analysis provides an insight into market dynamics and industry competition

KEY DELIVERABLES

Market is segmented based on product type, technology, application and geography.

MARKET BY PRODUCT TYPE

• Implantable Coronary Drug Eluting Stents
• Implantable Bio-Absorbable Stents
• Implantable Contraceptive Drug Delivery Devices
• Implantable Intraocular Drug Delivery Devices
• Implantable Brachytherapy Seeds
• Implantable Drug Infusion Pumps

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David C
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Implantable Drug Delivery Devices Market Key Players : Bayer Healthcare, Boston Scientific Corporation, Allergan Inc., Medtronic Inc., Merck, Bausch and Lomb, Inc. here

News-ID: 1380699 • Views:

More Releases from Allied Market Research

Energy Logistics Market Growing at 14.7% CAGR to Hit $1,383.7 Billion | Growth, Share Analysis
Energy Logistics Market Growing at 14.7% CAGR to Hit $1,383.7 Billion | Growth, …
𝐄𝐧𝐞𝐫𝐠𝐲 𝐋𝐨𝐠𝐢𝐬𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 by Application (Oil & Gas, Renewable Energy, Power Generation, Energy Mining), by End-User (Government Sector, Private Sector), by Mode of Transport (Railways, Airways, Roadways, Waterways): Global Opportunity Analysis and Industry Forecast, 2021-2031". As per the report, the global energy logistics industry accounted for $351.2 billion in 2021, and is expected to reach $1,383.7 billion by 2031, growing at a CAGR of 14.7% from 2022 to 2031. 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞
Avocado Puree Market to Show Exponential Growth by 2031 | Worldwide Value $726.6 Million
Avocado Puree Market to Show Exponential Growth by 2031 | Worldwide Value $726.6 …
According to a new report published by Allied Market Research, titled, "Avocado Puree Market," The avocado puree market size was valued at $480.30 million in 2021, and is estimated to reach $726.6 million by 2031, growing at a CAGR of 4.3% from 2022 to 2031. Request Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/A16925 Avocado is usually found in the warm and tropical climate of Mexico and Central & South America. It serves as
Global Train Communication Gateways Systems Market Analysis: Trends, Drivers, and Opportunities 2032
Global Train Communication Gateways Systems Market Analysis: Trends, Drivers, an …
According to a new report published by Allied Market Research, the train communication gateways systems market size was valued at $124.32 million in 2022, and is estimated to reach $1.3 billion by 2032, growing at a CAGR of 26.1% from 2023 to 2032. Train communication gateways refer to the products and solutions offered by companies to address the growing need for interconnected and intelligent train systems. These gateways facilitate the integration
Nutraceutical Ingredients Market is Booming Worldwide at a Significant Growth by 2031
Nutraceutical Ingredients Market is Booming Worldwide at a Significant Growth by …
According to a new report published by Allied Market Research, titled, "Nutraceutical Ingredients Market," The nutraceutical ingredients market size was valued at $163.9 billion in 2021, and is estimated to reach $327.3 billion by 2031, growing at a CAGR of 7.3% from 2022 to 2031. Request Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/370 The most popular category of components for nutraceuticals will continue to be nutrients, which include proteins, fibers, and different specific

All 5 Releases


More Releases for Implantable

Nanotechnology in Medical Devices Market 2028 by Implantable Materials, Active I …
The Insight Partners analysts forecasts the latest report on “Global Nanotechnology in Medical Devices Market (Covid-19) Impact and Analysis by 2028”, according to report; The Nanotechnology in Medical Devices Market report covers the overall and all-inclusive analysis of Market with all its factors that have an impact on market growth. This report is anchored on the thorough qualitative and quantitative assessment of the Nanotechnology in Medical Devices Market. The study
Nanomedical Devices Market Highest CAGR of 10.29% by 2023 | By Types Implantable …
The Global Nano Medical Devices Market is expected to grow at a CAGR of 10.29% during Forecasted Period 2017-2023. Nanomedical Devices Market - Segmentation The global Nanomedical Devices Market has been segmented on the basis of applications, end users, types, and lastly region. As per application-based segmentation, this market has been segmented into disease treatment & diagnosis, drug release regulation and other. Disease treatment & diagnosis has been sub-segmented into cancer, cardiovascular
Nanomedical Devices Market Highest CAGR of 10.29% by 2023 | By Types Implantable …
Nanomedical Devices Market - Segmentation The global nanomedical devices market has been segmented on the basis of applications, end users, types, and lastly region. As per application-based segmentation, this market has been segmented into disease treatment & diagnosis, drug release regulation and other. Disease treatment & diagnosis has been sub-segmented into cancer, cardiovascular diseases neurological diseases, and other. With regards to end users, the market has been segmented into clinics, hospitals,
Active Implantable Medical Devices Market (Implantable Cardioverter Defibrillato …
Global Active Implantable Medical Devices Market 2018 report includes Active Implantable Medical Devices Market Size, Revenue, market Share, Active Implantable Medical Devices industry volume, market Trends, Active Implantable Medical Devices Growth aspects. A wide range of applications, Utilization ratio, Supply and demand analysis are also consist in the report. It shows manufacturing capacity, Active Implantable Medical Devices Price during the Forecast period from 2018 to 2025. For In depth Information Get
Active Implantable Medical Devices Market by Product Type (Pacemaker, Implantabl …
The Global Active Implantable Medical Devices Market by product type (pacemaker, implantable cardioverter defibrillator, cardiac resynchronization therapy devices, neurostimulator, drug infusion pump, implantable loop recorder, cochlear implant, and others), and region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 16,721.2 million in 2016 and is projected to exhibit a CAGR of 5.4% over the forecast period (2017–2025), as highlighted in a new
Implantable Cardioverter Defibrillators Contribute Largest Revenue to the Global …
According to the study, the global active implantable medical devices market is likely to grow from $17.0 billion in 2016 to $28.9 billion by 2023. Technological advancements, increasing prevalence of cardiovascular diseases, rising healthcare expenditures and increasing research and development activities have been driving the growth of the global active implantable medical devices market. The market is further expected to gain revenue due to increasing geriatric population and incidence of